These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 1327295)

  • 1. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients.
    Lok AS; Chien D; Choo QL; Chan TM; Chiu EK; Cheng IK; Houghton M; Kuo G
    Hepatology; 1993 Sep; 18(3):497-502. PubMed ID: 7689528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical significance of virus markers].
    Nihon Naika Gakkai Zasshi; 1991 Oct; 80(10):1650-61. PubMed ID: 1774532
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical and virological analysis of the non-A, non-B hepatitis negative for HCV antibody (anti-C-100)].
    Kamimura T; Miyajima T; Okoshi S; Kojima H; Asakura H; Shimotono K
    Nihon Rinsho; 1991 Feb; 49(2):409-11. PubMed ID: 1849201
    [No Abstract]   [Full Text] [Related]  

  • 4. [Usefulness of HCV-ELISA using synthetic peptide].
    Takahashi T; Hayashi N; Shikata T
    Nihon Rinsho; 1991 Feb; 49(2):347-50. PubMed ID: 1849192
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnostic and clinical implications of the different genotypes of hepatitis C virus.
    Bukh J; Miller RH
    Hepatology; 1994 Jul; 20(1 Pt 1):256-9. PubMed ID: 7517384
    [No Abstract]   [Full Text] [Related]  

  • 6. [Characterization of hepatitis C related markers and control of hepatitis C infection].
    Yoshizawa H
    Nihon Koshu Eisei Zasshi; 1992 Aug; 39(8):441-4. PubMed ID: 1327295
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatitis C virus].
    Roggendorf M; Schlipköter U
    Beitr Infusionsther; 1991; 28():13-21. PubMed ID: 1725610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sequential monitoring of various HCV-related markers in chronic hepatitis C with interferon treatment].
    Nagayama R; Shoji S; Miyake K
    Nihon Rinsho; 1994 Jul; 52(7):1789-93. PubMed ID: 7521419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serodiagnosis of hepatitis C by a recombinant hepatitis C virus protein].
    Hayashi N; Yuki N; Kasahara A; Fusamoto H; Kamada T
    Nihon Rinsho; 1993 Feb; 51(2):329-33. PubMed ID: 7681883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing for HCV markers.
    Reesink HW; van der Poel CL; Bresters D; Cuypers HT; Zaaijer H; Lelie PN
    Dev Biol Stand; 1993; 81():77-84. PubMed ID: 7513661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Post-transfusional hepatitis].
    González A; Esteban JI
    Sangre (Barc); 1993 Jun; 38(3):193-200. PubMed ID: 7692610
    [No Abstract]   [Full Text] [Related]  

  • 12. [Transfusion safety].
    Aprili G
    Haematologica; 1991 Jun; 76 Suppl 3():385-94. PubMed ID: 1752537
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.